The Culture-Repopulating Ability Assays and Incubation in Low Oxygen: A Simple Way to Test Drugs on Leukaemia Stem or Progenitor Cells
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
5374-5383
Author(s):
Maria Grazia Cipolleschi, Elisabetta Rovida and Persio Dello Sbarba
How Recent Advances in High-risk Myelodysplastic Syndrome Physiopathology May Impact Future Treatments
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
5362-5373
Author(s):
Thomas Cluzeau, Guillaume Robert, Arnaud Jacquel and Patrick Auberger
Editorial (Hot Topics: Naturally Occurring Molecules and Anticancer Combination Therapies in the Era of Personalized Medicine and Economic Crisis)
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
5325-5326
Author(s):
Silvio Naviglio and Fulvio Della Ragione
Comparison of Uptake Mechanisms for Anthracyclines in Human Leukemic Cells
Journal:
Current Drug Delivery
Volume:
10
Page:
404-412
Author(s):
Hazhar Karim, Alex Bogason, Hasanuzzaman Bhuiyan, Alan K. Fotoohi, Pierre Lafolie and Sigurd Vitols
Folic Acid Conjugated Chitosan Nanoparticles for Tumor Targeting of Therapeutic and Imaging Agents
Journal:
Pharmaceutical Nanotechnology
Volume:
1
Page:
184-203
Author(s):
Driton Vllasaliu, Luca Casettari, Giulia Bonacucina, Marco Cespi, Giovanni Filippo Palmieri and Lisbeth Illum
Lysine Acetyltransferases CBP and p300 as Therapeutic Targets in Cognitive and Neurodegenerative Disorders
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
5051-5064
Author(s):
Luis M. Valor, Jose Viosca, Jose P. Lopez-Atalaya and Angel Barco
Nuclear Hormone Receptors and Female Reproduction
Journal:
Current Molecular Medicine
Volume:
13
Page:
1066-1078
Author(s):
A. Pestka, J. S. Fitzgerald, B. Toth, U. R. Markert and U. Jeschke
Phytochemistry and Pharmacognosy of Naturally Occurring Prenyloxyanthraquinones
Journal:
Current Drug Targets
Volume:
14
Page:
959-963
Author(s):
Francesco Epifano, Serena Fiorito, Giuseppe Carlucci, Marcello Locatelli and Salvatore Genovese
Tipping the Balance Between Life and Death: Targeting Histone Acetylation for Cancer Therapy
Journal:
Drug Delivery Letters
Volume:
3
Page:
149-158
Author(s):
Stephen A. Watt and Andrew P. South
Severe Hypoglycemia Due to Possible Interaction Between Glibenclamide and Sorafenib in a Patient with Hepatocellular Carcinoma
Journal:
Current Drug Safety
Volume:
8
Page:
148-152
Author(s):
Andreas Holstein, Peter Kovacs and Winfried Beil